Industry Growth Insights published a new data on “Non-Invasive Prenatal Testing Devices Market”. The research report is titled “Non-Invasive Prenatal Testing Devices Market research by Types (Ultrasound Devices, Next-Generation Sequencing Systems, Polymerase Chain Reaction Instruments, Microarrays, Other), By Applications (Hospital, Clinics, Research Laboratories), By Players/Companies Philips, Illumina, Thermo Fisher, Beckman Coulter, Pacific Biosciences, Oxford Nanopore, QIAGEN, GE Healthcare, BGI, HYK Gene, Roche, Berry Genomics, CapitalBio, LabCorp, LifeLabs Genetics, LifeCodexx, Natera, Quest Diagnostics, Sequenom, Genpharm Services”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Non-Invasive Prenatal Testing Devices Market Research Report
By Type
Ultrasound Devices, Next-Generation Sequencing Systems, Polymerase Chain Reaction Instruments, Microarrays, Other
By Application
Hospital, Clinics, Research Laboratories
By Companies
Philips, Illumina, Thermo Fisher, Beckman Coulter, Pacific Biosciences, Oxford Nanopore, QIAGEN, GE Healthcare, BGI, HYK Gene, Roche, Berry Genomics, CapitalBio, LabCorp, LifeLabs Genetics, LifeCodexx, Natera, Quest Diagnostics, Sequenom, Genpharm Services
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Non-Invasive Prenatal Testing Devices Market Report Segments:
The global Non-Invasive Prenatal Testing Devices market is segmented on the basis of:
Types
Ultrasound Devices, Next-Generation Sequencing Systems, Polymerase Chain Reaction Instruments, Microarrays, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinics, Research Laboratories
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Philips
- Illumina
- Thermo Fisher
- Beckman Coulter
- Pacific Biosciences
- Oxford Nanopore
- QIAGEN
- GE Healthcare
- BGI
- HYK Gene
- Roche
- Berry Genomics
- CapitalBio
- LabCorp
- LifeLabs Genetics
- LifeCodexx
- Natera
- Quest Diagnostics
- Sequenom
- Genpharm Services
Highlights of The Non-Invasive Prenatal Testing Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Ultrasound Devices
- Next-Generation Sequencing Systems
- Polymerase Chain Reaction Instruments
- Microarrays
- Other
- By Application:
- Hospital
- Clinics
- Research Laboratories
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Non-Invasive Prenatal Testing Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Non-invasive prenatal testing devices are medical tools that can be used to detect certain genetic abnormalities in a pregnant woman. These tests use a small amount of blood or other bodily fluid from the pregnant woman and are often painless.
Some of the major companies in the non-invasive prenatal testing devices market are Philips, Illumina, Thermo Fisher, Beckman Coulter, Pacific Biosciences, Oxford Nanopore, QIAGEN, GE Healthcare, BGI, HYK Gene, Roche, Berry Genomics, CapitalBio, LabCorp, LifeLabs Genetics, LifeCodexx, Natera, Quest Diagnostics, Sequenom, Genpharm Services.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Non-Invasive Prenatal Testing Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Non-Invasive Prenatal Testing Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Non-Invasive Prenatal Testing Devices Market - Supply Chain
4.5. Global Non-Invasive Prenatal Testing Devices Market Forecast
4.5.1. Non-Invasive Prenatal Testing Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Non-Invasive Prenatal Testing Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Non-Invasive Prenatal Testing Devices Market Absolute $ Opportunity
5. Global Non-Invasive Prenatal Testing Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Non-Invasive Prenatal Testing Devices Market Size and Volume Forecast by Type
5.3.1. Ultrasound Devices
5.3.2. Next-Generation Sequencing Systems
5.3.3. Polymerase Chain Reaction Instruments
5.3.4. Microarrays
5.3.5. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Non-Invasive Prenatal Testing Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Non-Invasive Prenatal Testing Devices Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinics
6.3.3. Research Laboratories
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Non-Invasive Prenatal Testing Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Non-Invasive Prenatal Testing Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Non-Invasive Prenatal Testing Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Non-Invasive Prenatal Testing Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Non-Invasive Prenatal Testing Devices Demand Share Forecast, 2019-2026
9. North America Non-Invasive Prenatal Testing Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Non-Invasive Prenatal Testing Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Non-Invasive Prenatal Testing Devices Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinics
9.4.3. Research Laboratories
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Non-Invasive Prenatal Testing Devices Market Size and Volume Forecast by Type
9.7.1. Ultrasound Devices
9.7.2. Next-Generation Sequencing Systems
9.7.3. Polymerase Chain Reaction Instruments
9.7.4. Microarrays
9.7.5. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Non-Invasive Prenatal Testing Devices Demand Share Forecast, 2019-2026
10. Latin America Non-Invasive Prenatal Testing Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Non-Invasive Prenatal Testing Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Non-Invasive Prenatal Testing Devices Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinics
10.4.3. Research Laboratories
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Non-Invasive Prenatal Testing Devices Market Size and Volume Forecast by Type
10.7.1. Ultrasound Devices
10.7.2. Next-Generation Sequencing Systems
10.7.3. Polymerase Chain Reaction Instruments
10.7.4. Microarrays
10.7.5. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Non-Invasive Prenatal Testing Devices Demand Share Forecast, 2019-2026
11. Europe Non-Invasive Prenatal Testing Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Non-Invasive Prenatal Testing Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Non-Invasive Prenatal Testing Devices Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinics
11.4.3. Research Laboratories
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Non-Invasive Prenatal Testing Devices Market Size and Volume Forecast by Type
11.7.1. Ultrasound Devices
11.7.2. Next-Generation Sequencing Systems
11.7.3. Polymerase Chain Reaction Instruments
11.7.4. Microarrays
11.7.5. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Non-Invasive Prenatal Testing Devices Demand Share, 2019-2026
12. Asia Pacific Non-Invasive Prenatal Testing Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Non-Invasive Prenatal Testing Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Non-Invasive Prenatal Testing Devices Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinics
12.4.3. Research Laboratories
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Non-Invasive Prenatal Testing Devices Market Size and Volume Forecast by Type
12.7.1. Ultrasound Devices
12.7.2. Next-Generation Sequencing Systems
12.7.3. Polymerase Chain Reaction Instruments
12.7.4. Microarrays
12.7.5. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Non-Invasive Prenatal Testing Devices Demand Share, 2019-2026
13. Middle East & Africa Non-Invasive Prenatal Testing Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Non-Invasive Prenatal Testing Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Non-Invasive Prenatal Testing Devices Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinics
13.4.3. Research Laboratories
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Non-Invasive Prenatal Testing Devices Market Size and Volume Forecast by Type
13.7.1. Ultrasound Devices
13.7.2. Next-Generation Sequencing Systems
13.7.3. Polymerase Chain Reaction Instruments
13.7.4. Microarrays
13.7.5. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Non-Invasive Prenatal Testing Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Non-Invasive Prenatal Testing Devices Market: Market Share Analysis
14.2. Non-Invasive Prenatal Testing Devices Distributors and Customers
14.3. Non-Invasive Prenatal Testing Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Philips
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Illumina
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Thermo Fisher
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Beckman Coulter
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Pacific Biosciences
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Oxford Nanopore
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. QIAGEN
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. GE Healthcare
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. BGI
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. HYK Gene
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Roche
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Berry Genomics
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. CapitalBio
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. LabCorp
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. LifeLabs Genetics
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. LifeCodexx
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Natera
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Quest Diagnostics
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Sequenom
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Genpharm Services
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
